>
产品中心 >
monoclonal_antibody >
BioXcell/InVivoPlus小鼠IgG2a同型对照，特异性未知/学术或非盈利折扣25MG/BP0085-A025mg
About InVivoMAb anti-mouse RANKL (CD254)
The IK22/5 monoclonal antibody reacts with mouse RANKL (receptor activator of nuclear factor kappa-B ligand) also known as CD254 and TRANCE (TNF-related activation-induced cytokine). RANKL is a 35 kDa type II membrane protein that belongs to the TNF superfamily. RANKL is expressed on activated T lymphocytes in the lung, thymus, and lymph nodes and on osteoclasts. RANKL has been implicated in the regulation of T cell and dendritic cell interactions as well as osteoclast differentiation. Additionally, RANKL was found to be critical for osteoclast differentiation.
InVivoMAb anti-mouse RANKL (CD254) Specifications
| Isotype | Rat IgG2a, κ |
| Recommended Isotype Control(s) | InVivoMAb rat IgG2a isotype control, anti-trinitrophenol(BE0089) |
| Recommended InVivoPure Dilution Buffer | InVivoPure pH 6.5 Dilution Buffer(IP0065) |
| Immunogen | NSO-derived recombinant mouse RANKL |
| Reported Applications | in vivo RANKL blockade |
| Endotoxin |
|
| Purity |
|
| Formulation |
|
| Sterility | 0.2 μM filtered |
| Production | Purified from tissue culture supernatant in an animal free facility |
| Purification | Protein G |
| Storage | The antibody solution should be stored at the stock concentration at 4°C. Do not freeze. |
| RRID | AB_10949003 |
| Molecular Weight | 150 kDa |
